• 1
    Bousquet J, Lockey RF, Malling HJ. Allergen immunotherapy – therapeutic vaccines for allergic diseases. Allergy 1998;53 Suppl. 44:442.
  • 2
    Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468475.
  • 3
    Adkinson NF Jr, Eggleston PA, Eney D, et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 1997;336:324331.
  • 4
    Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;154:41874194.
  • 5
    Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:21232130.
  • 6
    Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98106.
  • 7
    Broman P, Moller E. Lymphocyte transformation by grass pollen allergens. A study of atopic patients receiving immunotherapy. Allergy 1984;39:297308.
  • 8
    Baskar S, Hamilton RG, Norman PS, Ansari AA. Grass immunotherapy induces inhibition of allergen-specific human peripheral blood mononuclear cell proliferation. Int Arch Allergy Immunol 1997;112:184190.
  • 9
    Lichtenstein LM, Ishizaka K, Norman PS, Sobotka AK, Hill BM. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest 1973;52:472482.
  • 10
    Moller C, Dreborg S, Einarsson R. Immunotherapy to deciduous tree pollens: specific IgE and IgG antibody patterns. Clin Allergy 1987;17:551562.
  • 11
    Pastorello EA, Pravettoni V, Incorvaia C, et al. Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever. Allergy 1992;47:281290.
  • 12
    Bousquet J, Becker WM, Hejjaoui A, et al. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991;88:4353.
  • 13
    Moverare R, Rak S, Elfman L. Allergen-specific increase in interleukin (IL)-4 and IL-5 secretion from peripheral blood mononuclear cells during birch-pollen immunotherapy. Allergy 1998;53:275281.
  • 14
    Benjaponpitak S, Oro A, Maguire P, Marinkovich V, Dekruyff RH, Umetsu DT. The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy. J Allergy Clin Immunol 1999;103:468475.
  • 15
    Moverare R, Elfman L, Bjornsson E, Stalenheim G. Changes in cytokine production in vitro during the early phase of birch-pollen immunotherapy. Scand J Immunol 2000;52:200206.DOI: 10.1046/j.1365-3083.2000.00764.x
  • 16
    Richter M, Sehon AH, Gordon J, Gregoire C, Rose B. Demonstration of reagin of a new specificity in sera of treated ragweed-sensitive persons. J Allergy 1958;29:287292.
  • 17
    Birkner T, Rumpold H, Jarolim E, et al. Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Correlation with clinical response. Allergy 1990;45:418426.
  • 18
    Juarez C, Blanca M, Miranda A, et al. Specific IgE antibodies to vespids in the course of immunotherapy with Vespula germanica administered to patients sensitized to Polistes dominulus. Allergy 1992;47:299302.
  • 19
    Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999;29:896904.DOI: 10.1046/j.1365-2222.1999.00653.x
  • 20
    Jarolim E, Rumpold H, Endler AT, et al. IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa. Allergy 1989;44:385395.
  • 21
    Valenta R, Duchene M, Ebner C, et al. Profilins constitute a novel family of functional plant pan-allergens. J Exp Med 1992;175:377385.
  • 22
    Twardosz A, Hayek B, Seiberler S, et al. Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4. Biochem Biophys Res Commun 1997;239:197204.DOI: 10.1006/bbrc.1997.6860
  • 23
    Moverare R, Sorva R, Metso T, Vesterinen E, Elfman L, Haahtela T. Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations. Ann Allergy Asthma Immunol 2001;86:337342.
  • 24
    Neville DM Jr. Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem 1971;246:63286334.
  • 25
    Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:43504354.
  • 26
    Ferreira FD, Hoffmann Sommergruber K, Breiteneder H, et al. Purification and characterization of recombinant Bet v 1 the major birch pollen allergen. Immunological equivalence to natural Bet v 1. J Biol Chem 1993;268:1957419580.
  • 27
    Valenta R, Duchene M, Vrtala S, et al. Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J Allergy Clin Immunol 1991;88:889894.
  • 28
    Pauli G, Oster JP, Deviller P, et al. Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: diagnostic value for birch pollen and associated allergies. J Allergy Clin Immunol 1996;97:11001109.
  • 29
    Engel E, Richter K, Obermeyer G, et al. Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF–hand calcium–binding domains. J Biol Chem 1997;272:2863028637.
  • 30
    Laffer S, Spitzauer S, Susani M, et al. Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations. J Allergy Clin Immunol 1996;98:652658.
  • 31
    Elfman L, Svensson M, Lidholm J, Pauli G, Valenta R. Different profiles in specific IgE to rBet v 1 and rBet v 2 in patients allergic to birch pollen from six countries. Intl Arch Allergy Immunol 1997;113:249251.
  • 32
    Van Ree R, Fernandez Rivas M, Cuevas M, Van Wijngaarden M, Aalberse RC. Pollen-related allergy to peach and apple: an important role for profilin. J Allergy Clin Immunol 1995;95:726734.
  • 33
    Ebner C, Hirschwehr R, Bauer L, et al. Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 1995;95:962969.
  • 34
    Valenta R, Kraft D. Type 1 allergic reactions to plant-derived food: a consequence of primary sensitization to pollen allergens. J Allergy Clin Immunol 1996;97:893895.
  • 35
    Rossi RE, Monasterolo G, Operti D, Corsi M. Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP system in patients with pollen–related allergy to birch and apple. Allergy 1996;51:940945.
  • 36
    Karamloo F, Wangorsch A, Kasahara H, et al. Phenylcoumaran benzylic ether and isoflavonoid reductases are a new class of cross-reactive allergens in birch pollen, fruits and vegetables. Eur J Biochem 2001;268:531053320.DOI: 10.1046/j.0014-2956.2001.02463.x
  • 37
    Cadot P, Diaz JF, Proost P, et al. Purification and characterization of an 18-kD allergen of birch (Betula verrucosa) pollen: identification as a cyclophilin. J Allergy Clin Immunol 2000;105:286291.
  • 38
    Seiberler S, Scheiner O, Kraft D, Lonsdale D, Valenta R. Characterization of a birch pollen allergen, Bet v III, representing a novel class of Ca2+ binding proteins: specific expression in mature pollen and dependence of patients' IgE binding on protein–bound Ca2+. EMBO J 1994;13:34813486.
  • 39
    Holt PG. Development of T-cell memory against inhalant allergens: risks for the future. Clin Exp Allergy 1999;29 Suppl. 2:813.
  • 40
    Van Ree R, Antonicelli L, Akkerdaas JH, Garritani MS, Aalberse RC, Bonifazi F. Possible induction of food allergy during mite immunotherapy. Allergy 1996;51:108113.
  • 41
    Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;31:13921397.
  • 42
    Des Roches A, Paradis L, Menardo JL, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997;99:450453.